Janiec et al. analyzed long-term outcomes in patients with a history of infantile hypercalcemia, both with mutations in CYP24A1 or SLC34A1, and demonstrated that these patients are at an increased risk of developing progressive chronic kidney disease. The gene discussed is SLC34A1; the disease is hypercalcemia disease.